danish national birth cohort
Recently Published Documents


TOTAL DOCUMENTS

194
(FIVE YEARS 28)

H-INDEX

37
(FIVE YEARS 4)

Vaccine ◽  
2021 ◽  
Vol 39 (43) ◽  
pp. 6364-6369
Author(s):  
Anna Melgaard ◽  
Lene Wulff Krogsgaard ◽  
Tina Hovgaard Lützen ◽  
Oleguer Plana-Ripoll ◽  
Bodil Hammer Bech ◽  
...  

2021 ◽  
pp. 140349482110366
Author(s):  
Martin Bernstorff ◽  
Charlotte Ulrikka Rask ◽  
Dorte Rytter ◽  
Stefan Nygaard Hansen ◽  
Bodil Hammer Bech

Aims: This study aimed to examine the association between multiple health complaints (MHC) in pre-adolescence and prescription redemption in adolescence. Methods: This was a nationwide population-based study based on the Danish National Birth Cohort for an average of 6.9 years (2010–2018). A total of 96,382 children were invited at the age of 11. A modified version of the Health Behaviour in School Children Symptom Checklist was dichotomised into the World Health Organization’s definition of MHC (⩾2 complaints, each with a frequency of at least weekly, yes/no). The number of prescriptions was retrieved from Danish registries. Negative binomial regression estimated incidence rate ratios (IRRs) comparing children with MHC to children without. Prescription redemption was further stratified by psychiatric/somatic medication and into subtypes of prescriptions. Results: A total of 47,365 (49.1%) children participated ( Mage=11.2 years, 52% girls). MHC were reported by 10.3%. The unadjusted IRR (MHC vs. no MHC) of all types of redemptions was 1.57 (95% confidence interval (CI) 1.49–1.64). Results were robust to adjustment for socio-demographic variables and somatic/psychiatric morbidity at baseline (IRR=1.47; 95% CI 1.40–1.54). Associations were especially strong for psychiatric medication (adjusted IRR=3.88; 95% CI 3.43–4.40) and were modified by neither sex nor maternal education. Conclusions: MHC in pre-adolescents predict prescription redemption. This implies that changes in MHC might be indicative of changes in public health. This requires further study, as the cause of a change in reporting of symptoms might also cause a change in treatment response. The latter determines whether prescriptions are treating ill-being or needlessly medicalising subjective symptoms.


2021 ◽  
pp. 140349482110197
Author(s):  
Anne Marie Ladehoff Thomsen ◽  
Cecilia Høst Ramlau-Hansen ◽  
Jørn Olsen ◽  
Nis Brix ◽  
Anne-Marie Nybo Andersen ◽  
...  

Aims: Concerns have been raised about the potential negative biological effect of postponed parenthood upon the health of subsequent generations, including reproductive health. This study aimed to estimate if high parental age at birth was associated with accelerated pubertal timing in offspring. Methods: In this large-scale cohort study, 15,819 children born by mothers in the Danish National Birth Cohort from 2000 to 2003 participated in a nationwide puberty cohort (participation rate 71%). Between 2012 and 2018, the children reported half-yearly information on pubertal status using web-based questionnaires from 11 years throughout puberty or 18 years of age. Information on parental age was drawn from nationwide registers. We estimated adjusted mean differences in months for age at attaining the pubertal milestones and pubertal timing overall between the pre-specified parental age groups: 20–29 (reference), 30–34 and advanced parental age groups (35–44 years for mothers and >35 years for fathers). Results: Overall, parental age at birth of the child was not associated with pubertal timing in daughters or sons. For sons of older fathers (>35 years), we observed indications towards slightly earlier pubertal timing in the range of 0.3–2.4 months for nearly all pubertal milestones, but all confidence intervals were wide, and many included the null. Conclusions: We found no strong association between parental age and timing of puberty, and we find it unlikely that the decreasing age in pubertal timing is a result of parental decision to delay childbearing.


Nutrients ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 1676
Author(s):  
Ellen Aagaard Nohr ◽  
Sanne Wolff ◽  
Helene Kirkegaard ◽  
Chunsen Wu ◽  
Anne-Marie Nybo Andersen ◽  
...  

Maternal obesity is associated with impaired fetal and neonatal survival, but underlying mechanisms are poorly understood. We examined how prepregnancy BMI and early gestational weight gain (GWG) were associated with cause-specific stillbirth and neonatal death. In 85,822 pregnancies in the Danish National Birth Cohort (1996–2002), we identified causes of death from medical records for 272 late stillbirths and 228 neonatal deaths. Prepregnancy BMI and early GWG derived from an early pregnancy interview and Cox regression were used to estimate associations with stillbirth or neonatal death as a combined outcome and nine specific cause-of-death categories. Compared to women with normal weight, risk of stillbirth or neonatal death was increased by 66% with overweight and 78% with obesity. Especially deaths due to placental dysfunction, umbilical cord complications, intrapartum events, and infections were increased in women with obesity. More stillbirths and neonatal deaths were observed in women with BMI < 25 and low GWG. Additionally, unexplained intrauterine death was increased with low GWG, while more early stillbirths were seen with both low and high GWG. In conclusion, causes of death that relate to vascular and metabolic disturbances were increased in women with obesity. Low early GWG in women of normal weight deserves more clinical attention.


2020 ◽  
Vol 83 (6) ◽  
pp. 1625-1632 ◽  
Author(s):  
Jonathan Groot ◽  
Anne-Marie Nybo Andersen ◽  
Christoffer Blegvad ◽  
Angela Pinot de Moira ◽  
Lone Skov

Sign in / Sign up

Export Citation Format

Share Document